Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.

International Journal of Molecular Sciences
Yohan SeoSang-Won Lee

Abstract

Lupus nephritis (LN) is the most frequent phenotype in patients with systemic lupus erythematosus (SLE) and has a high rate of progression to end-stage renal disease, in spite of intensive treatment and maintenance therapies. Recent evidence suggests that protease-activated receptor-2 (PAR2) is a therapeutic target for glomerulonephritis. In this study, we performed a cell-based high-throughput screening and identified a novel potent PAR2 antagonist, punicalagin (PCG, a major polyphenol enriched in pomegranate), and evaluated the effects of PCG on LN. The effect of PCG on PAR2 inhibition was observed in the human podocyte cell line and its effect on LN was evaluated in NZB/W F1 mice. In the human podocyte cell line, PCG potently inhibited PAR2 (IC50 = 1.5 ± 0.03 µM) and significantly reduced the PAR2-mediated activation of ERK1/2 and NF-κB signaling pathway. In addition, PCG significantly decreased PAR2-induced increases in ICAM-1 and VCAM-1 as well as in IL-8, IFN-γ, and TNF-α expression. Notably, the intraperitoneal administration of PCG significantly alleviated kidney injury and splenomegaly and reduced proteinuria and renal ICAM-1 and VCAM-1 expression in NZB/W F1 mice. Our results suggest that PCG has beneficial effects on...Continue Reading

References

Jan 1, 1985·Advances in Immunology·A N Theofilopoulos, F J Dixon
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y WangL A Matis
Apr 4, 1998·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·M R D'AndreaP Andrade-Gordon
Nov 21, 2000·The Journal of Experimental Medicine·M BattenF Mackay
Mar 20, 2003·American Journal of Physiology. Renal Physiology·Yu GuiMorley D Hollenberg
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Giuseppe GrandalianoFrancesco P Schena
Mar 27, 2004·Physiological Reviews·Valeria S Ossovskaya, Nigel W Bunnett
Dec 24, 2004·The New England Journal of Medicine·Philip F Halloran
Feb 24, 2006·The Journal of Experimental Medicine·Marc EhlersJeffrey V Ravetch
Feb 25, 2006·American Journal of Respiratory Cell and Molecular Biology·Rithwik RamachandranSteven J Compton
Mar 19, 2008·Journal of Leukocyte Biology·V ShpacovitchM Steinhoff
Jun 24, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Chintan PatelM G Soni
Sep 9, 2008·Trends in Molecular Medicine·Keren BorensztajnC Arnold Spek
Feb 16, 2010·Nature Reviews. Immunology·Margarida Saraiva, Anne O'Garra
May 8, 2010·Veterinary Pathology·J B Rottman, C R Willis
Feb 1, 2011·Pharmacology & Therapeutics·Mark N AdamsJohn D Hooper
Mar 16, 2011·Journal of Biomedicine & Biotechnology·Daniel PerryLaurence Morel
Jun 28, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zheng LiuAnne Davidson
Oct 6, 2011·Seminars in Immunopathology·Andrea S Rothmeier, Wolfram Ruf
Dec 2, 2011·The New England Journal of Medicine·George C Tsokos
Jan 4, 2013·American Journal of Physiology. Renal Physiology·David A VeseyDavid P Fairlie
Apr 5, 2013·Arthritis and Rheumatism·Sang-Won LeeYong-Beom Park
Jun 29, 2013·Journal of Nephrology·Adeel Zubair, Marianne Frieri
Jul 23, 2014·Current Opinion in Rheumatology·Christine KonyaGeorge C Tsokos
Nov 26, 2014·Nature Reviews. Nephrology·Tak Mao Chan
Mar 5, 2016·Expert Opinion on Therapeutic Patents·Mei-Kwan YauDavid P Fairlie
Jul 6, 2016·Kidney International·Hans-Joachim Anders, Brad Rovin
Sep 11, 2016·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Susan Yung, Tak Mao Chan
Oct 14, 2016·American Journal of Physiology. Renal Physiology·Oleg PalyginAlexander Staruschenko
Jul 4, 2017·Nature Reviews. Nephrology·Feng YuMing-Hui Zhao

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
ELISA
enzyme-linked immunosorbent assay

Software Mentioned

MARS Data Analysis

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.